Study procedures | Screening | Baseline evaluation | Post-intervention evaluation | Two-month evaluation |
---|---|---|---|---|
Timepoint | − T1 | T0 | T1 | T2 |
Informed consent | + | Â | Â | Â |
Inclusion/exclusion criteria | + | Â | Â | Â |
Demographics | Â | + | Â | Â |
Randomization | Â | + | Â | Â |
Primary outcome measure | ||||
 3-day hand counts |  | + | + | + |
Secondary outcome measures | ||||
 Impairment | ||||
  Upper limb pain |  | + | + | + |
 Functional | ||||
  Arm Capacity and Movement Test (upper limb functional capacity) |  | + | + | + |
  REACH Scale (self-reported arm use) |  | + | + | + |
  Stroke impact scale—arm function |  | + | + | + |
  Stroke impact scale—arm strength |  | + | + | + |
Adverse events | Â | +* | +* | +* |